Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Key Results Semaglutide vs Sitagliptin HR 0.58 (95% CI, 0.510.65) 42% lower risk 1-yr absolute risk: 5.5% vs 8.6% NNT 31 Tirzepatide vs Sitagliptin HR 0.42 (95% CI, 0.310.57) 58% lower risk 1-yr absolute risk: 3.6% vs 7.5% NNT 26 Tirzepatide vs Semaglutide HR 0.86 (95% CI, 0.701.06) no statistically significant difference Safety: No excess signal for GI, infections, or serious AEs across GLP-1/dual arms
Understanding how GLP1R signalling protects the heart and blood vessels will optimize the therapeutic use and development of next-generation GLP1-based therapies with improved cardiovascular safety
Vi cng thc ti u, hm lng glutathione cao , sn phm mang n hiu qu lm trng da vt tri, ng thi nui dng ln da khe mnh v chng lo ha t bn trong
A FINAL WORD Regulating Acetaminophen If any over-the-counter drug deserves to be regulated, its acetaminophen
Eli Lilly has seen its shares surge in the last five years, with its diabetes drug Zepbound demonstrating strong results for weight loss
US$ 23.46
US$ 24.72
US$ 22.89
